Celularity Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Celularity Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Celularity Inc - Ordinary Shares - Class A
Rating: 0.91175
Author: Trendlyne DVM scores

about

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

1.32 -0.13 (-8.97%)

69.66% Fall from 52W High

126.7K

XNAS Volume

XNAS 22 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Bearish

27.5 / 100

No estimates available

Celularity Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celularity Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

69.66% Fall from 52W High

SWOT Analysis

Celularity Inc (Class A) Live Price Chart